ICD-10 is a large collection from a to Z, while icd-o only focuses on tumors.
When icd-o just began to be popularized and applied, ICD-10 has been deeply rooted in the hearts of the people.
For proficient people, it is easy to make empirical mistakes when they are new to the former.
Preconceived misconceptions about the composition of icd-o anatomical site coding.
Part II code of the Chinese scheme for tumor coding: always start with C, followed by ① - ③ icd-o-3 anatomical site code (including decimal point, accounting for 5 characters in total).
Here we begin the coding of icd-o-3. This code is an extension of ICD-10, but the C code here is purely anatomical code, and the C code of ICD-10 includes both anatomical code (such as c34.9 unspecified lung) and disease name code (such as c85.9 malignant lymphoma). Therefore, c85.9 and other disease name codes cannot be found in icd-o, but C42 (hematopoietic and reticuloendothelial system) and other improved anatomical code are added.
Those who have coded in person will complain about how difficult lymphoma and leukemia are to code, and the one who is listed in the difficulty list may be liver cancer.
C22 is almost always a name code in ICD-10, such as:
C22.0 hepatocellular carcinoma
C22.3 hepatic angiosarcoma and hepatic megaphagocytic (Kupffer) cell sarcoma
However, c22.2-c22.9 in icd-o-3 does not exist because it is only the anatomical site code.
The author boldly predicts that the new ICD-11 coding in the future is very likely to absorb such advantages to modify and formulate.
The similarities and differences between ICD-10 code and icd-o-3 anatomical part code can be understood by carefully looking at the coding manual.More recommended